We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable Biosensor Platform to Reduce Hospital-Acquired Infections

By HospiMedica International staff writers
Posted on 11 Oct 2024

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections, making them a significant cause of mortality. More...

Microorganisms contracted in hospitals are frequently resistant to many common antibiotics. By 2050, the number of deaths caused by drug-resistant infections is projected to rise to 10 million worldwide, posing a serious public health challenge. Early detection of nosocomial infections and effective disinfection of hospitals and healthcare facilities are crucial to reducing these numbers, but current methods have limitations. Researchers are now developing a bio-based disinfectant to eliminate key pathogens responsible for HAIs, integrated into a new, flexible, and portable biosensor platform.

The biosensor platform being developed by a collaborative team of researchers, including from AIMPLAS - Plastics Technology Centre (Valencia, Spain;) under the NOSOSENS Project, uses printed electrochemical sensors for rapid, selective detection of Staphylococcus aureus, a methicillin-resistant bacterium responsible for 11% of nosocomial infections. The standard method currently used in hospitals to prevent these infections involves pathogen detection through cell culture microscopy, with results typically available in four to five days. The NOSOSENS portable electrochemical biosensor platform, however, offers immediate, specific detection and quantification of bacteria from the Staphylococcus aureus family. The system will also feature data monitoring, management, and alert capabilities.

A key challenge with current cleaning products is that pathogens' antimicrobial resistance renders many disinfectants less effective. Stronger disinfectants, such as peracetic acid, are often required, but they can cause long-term surface damage and are unsuitable for daily use in healthcare settings. The NOSOSENS solution, however, is both highly biocidal and bio-based, making it biodegradable, less aggressive, and more environmentally friendly. The innovations will be tested using a portable, user-friendly system for early bacterial detection by healthcare personnel, alongside an effective and sustainable pathogen elimination system for surgical tools and surfaces. By integrating with the sensor platform, this system will optimize disinfection processes, improving safety against hospital-acquired infections. It will also enable rapid tracing, control, and elimination of surface colonization, reducing risks associated with hospital stays.

Related Links:
AIMPLAS


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.